Insmed Inc (NAS:INSM)
$ 56.85 -0.32 (-0.56%) Market Cap: 9.27 Bil Enterprise Value: 9.89 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Q4 2019 Insmed Inc Earnings Call Transcript

Feb 25, 2020 / 01:30PM GMT
Release Date Price: $26.34 (-11.76%)
Operator

Good day and welcome to the Insmed Fourth Quarter and Full Year 2019 Results Conference Call. (Operator Instructions)

Please note, this event is being recorded. I would now like to turn the conference over to Eleanor Barriser, Investor Relations. Please go ahead.

Eleanor Barriser;Argot Partners;Assistant Vice President
LLC

Thank you, Elissa. Good morning, and welcome to today's conference call to discuss our fourth quarter and full year financial results for 2019 and provide a business update. Please note this conference call features slides, which can be found through the webcast on the Events and Presentations page of the Insmed website. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today, and may involve risks and uncertainties that may cause actual results to differ materially from the results discussed in the forward-looking statements.

Please refer to our filings with the SEC,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot